Munenobu Kashiwa & Ryo Matsushita. (2019). Cost-utility analysis of palonosetron in the antiemetic regimen for cisplatin-containing highly emetogenic chemotherapy in Japan. BMC.
Chicago Style (17th ed.) CitationMunenobu Kashiwa and Ryo Matsushita. Cost-utility Analysis of Palonosetron in the Antiemetic Regimen for Cisplatin-containing Highly Emetogenic Chemotherapy in Japan. BMC, 2019.
MLA (9th ed.) CitationMunenobu Kashiwa and Ryo Matsushita. Cost-utility Analysis of Palonosetron in the Antiemetic Regimen for Cisplatin-containing Highly Emetogenic Chemotherapy in Japan. BMC, 2019.
Warning: These citations may not always be 100% accurate.